CAR T therapies for the treatment of oncological diseases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT05679895
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2023
Completion: Jun 30, 2027
Loading map...